Inici › Colitis ulcerosa › Texas › Tyler
Assaigs clínics de Colitis ulcerosa a Tyler, TX
14 estudis de Colitis ulcerosa busquen participants en centres de Tyler i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
ReclutantFase 3
- Tyler Research Institute ( Site 0294), Tyler
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 2
- Tyler Research Institute, Tyler
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
ReclutantFase 1/2Voluntaris sans benvinguts
- Xencor Investigative Site, Tyler
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 2
- Site US-004, Tyler
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 3
- Tyler Research Institute, LLC, Tyler
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
ReclutantFase 3
- Tyler Research Institute, Tyler
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
ReclutantFase 2
- Tyler Research Institute, Tyler
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 2
- Tyler Research Institute, Tyler
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
ReclutantFase 4
- Tyler Research Institute, LLC, Tyler
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 3
- Tyler Research Institute, LLC - Site Number: 8400095, Tyler
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 3
- Tyler Research Institute, LLC, Tyler
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 3
- Tyler Research Institute, LLC - Site Number: 8400095, Tyler
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
ReclutantFase 2
- Tyler Research Institute, LLC, Tyler
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
ReclutantFase 2
- Mirador Therapeutics Selected Site, Tyler
Assaigs de Colitis ulcerosa en altres ciutats
- New York City, NY23 estudis
- Orlando, FL22 estudis
- Miami, FL21 estudis
- Houston, TX17 estudis
- San Antonio, TX16 estudis
- Tacoma, WA15 estudis
- Chicago, IL15 estudis
- San Diego, CA15 estudis
- Colorado Springs, CO14 estudis
- Los Angeles, CA13 estudis
- St. Louis, MO13 estudis
- Washington, DC12 estudis
Altres estudis a Tyler
- Càncer de pulmó de cèl·lules no petites20 estudis
- Malaltia de Crohn16 estudis
- Càncer colorrectal8 estudis
- Insuficiència cardíaca8 estudis
- Càncer (tots els tipus)7 estudis
- Càncer d'ovari7 estudis
- Càncer d'endometri6 estudis
- Carcinoma de cèl·lules escamoses de cap i coll6 estudis
- Càncer de mama6 estudis
- Càncer metastàtic5 estudis
- Malaltia inflamatòria intestinal5 estudis
- Leucèmia limfàtica crònica5 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.